Jonathan Louw, MB.ChB, MBA, is the Group CEO of Honoris United Universities, the largest Pan-African Tertiary Education Institution with over 80,000 students. He is also a member of the South African National Dept. of Health's Pricing Committee that regulates the Country's healthcare pricing and a World Economic Forum New Champions Board Member.Prior to this he was the CEO of the South African National Blood Service (SANBS), catering to the collection, processing, testing and distribution of blood and related products across South Africa.He was also a Managing Director at one of the largest private equity firms in the Middle East, raising and deploying $1bn in hospitals and diagnostics in global markets. Prior to this, Dr. Louw worked at Adcock Ingram Holdings Limited (JSE:AIP) and was the CEO from Jan 2003 until May 2014. Dr. Louw led the IPO of Adcock Ingram when it separated from the JSE-Listed TigerBrands in 2008. Dr Louw first joined the pharmaceutical industry through AstraZeneca in 2000. He worked in the Department of Anesthesia at St. Mary's Hospital in London, having trained as an undergraduate at the University of Cape Town in the faculty of Medicine. He has also served as the President of the Pharmaceutical Industry Association of South Africa in 2009/10.